AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding AbCellera Biologics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 154 | 1 | 148 | −5 |
| Shares | 121.0M | 4.55M | 114.4M | −2.10M (−1.8%) |
| Value | $547.4M | $20.6M | $338.3M | −$188.5M (−35.8%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 4,598,626 | $13.6M | 0.00% |
| Exome Asset Management LLC | 514,900 | $1.52M | 1.36% |
| Tang Capital Management LLC | 461,699 | $1.37M | 0.14% |
| Citizens Financial Group Inc | 311,890 | $923.2K | 0.02% |
| Opaleye Management Inc. | 200,000 | $592.0K | 0.14% |
| Sanctuary Advisors, LLC | 105,924 | $398.3K | 0.00% |
| Prelude Capital Management, LLC | 120,900 | $357.9K | 0.03% |
| Salem Investment Counselors Inc | 63,000 | $186.5K | 0.01% |
| Headlands Technologies LLC | 49,393 | $146.2K | 0.02% |
| Signature Estate & Investment Advisors LLC | 39,668 | $117.4K | 0.00% |
| XTX Topco Ltd | 33,590 | $99.4K | 0.01% |
| Engineers Gate Manager LP | 30,761 | $91.1K | 0.00% |
| Dynamic Technology Lab Private Ltd | 29,112 | $86.0K | 0.01% |
| Virtu Financial LLC | 14,604 | $43.0K | 0.00% |
| Quadrature Capital Ltd | 13,929 | $41.4K | 0.00% |
| Woodline Partners LP | 12,163 | $36.0K | 0.00% |
| Kestra Advisory Services, LLC | 10,818 | $32.0K | 0.00% |
| Evergreen Capital Management LLC | 10,685 | $31.6K | 0.00% |
| EverSource Wealth Advisors, LLC | 5,000 | $16.3K | 0.00% |
| Bell Investment Advisors, Inc | 136 | $403 | 0.00% |
Sold out (25)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 4,547,315 | $20.6M |